The DOI matches its Crossref record; 491 of the 491 references it cites were found in a registry or an index.
Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies
Open accessAbstract
Ferroptosis is a non-apoptotic form of regulated cell death characterized by the lethal accumulation of iron-dependent membrane-localized lipid peroxides. It acts as an innate tumor suppressor mechanism and participates in the biological processes of tumors. Intriguingly, mesenchymal and dedifferentiated cancer cells, which are usually resistant to apoptosis and traditional therapies, are exquisitely vulnerable to ferroptosis, further underscoring its potential as a treatment approach for cancers, especially for refractory cancers. However, the impact of ferroptosis on cancer extends beyond its direct cytotoxic effect on tumor cells. Ferroptosis induction not only inhibits cancer but also promotes cancer development due to its potential negative impact on anticancer immunity. Thus, a comprehensive understanding of the role of ferroptosis in cancer is crucial for the successful translation of ferroptosis therapy from the laboratory to clinical applications. In this review, we provide an overview of the recent advancements in understanding ferroptosis in cancer, covering molecular mechanisms, biological functions, regulatory pathways, and interactions with the tumor microenvironment. We also summarize the potential applications of ferroptosis induction in immunotherapy, radiotherapy, and systemic therapy, as well as ferroptosis inhibition for cancer treatment in various conditions. We finally discuss ferroptosis markers, the current challenges and future directions of ferroptosis in the treatment of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 491
Energy Metabolism of the Osteoblast: Implications for Osteoporosis
Lee, W.-C., Guntur, A. R., Long, F., & Rosen, C. J. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00064 · Cited by 443 · cited 1×
“281,282 Glutaminolysis, TCA cycle and electron transport chain (ETC) are crucial for cysteine starvation-induced ferroptosis 160 (Fig.”
BackgroundEGFR activation limits the response of liver cancer to lenvatinib
Jin, H., Shi, Y., Lv, Y., Yuan, S., Ramirez, C. F. A., Lieftink, C., Wang, L., Wang, S., Wang, C., Dias, M. H., et al. (2021) · Nature · doi:10.1038/s41586-021-03741-7 · Cited by 440
Polyunsaturated fatty acids, part 1: Occurrence, biological activities and applications
GILL, I., & VALIVETY, R. (1997) · Trends in Biotechnology · doi:10.1016/s0167-7799(97)01076-7 · Cited by 431
Wnt/beta-catenin signaling confers ferroptosis resistance by targeting GPX4 in gastric cancer
Wang, Y., Zheng, L., Shang, W., Yang, Z., Li, T., Liu, F., Shao, W., Lv, L., Chai, L., Qu, L., et al. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-022-01008-w · Cited by 422
Dai, E., Han, L., Liu, J., Xie, Y., Zeh, H. J., Kang, R., Bai, L., & Tang, D. (2020) · Nature Communications · doi:10.1038/s41467-020-20154-8 · Cited by 420
Rapid evolutionary innovation during an Archaean genetic expansion
David, L. A., & Alm, E. J. (2011) · Nature · doi:10.1038/nature09649 · Cited by 411
Koskenkorva-Frank, T. S., Weiss, G., Koppenol, W. H., & Burckhardt, S. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.09.001 · Cited by 406
Hypoxia inhibits ferritinophagy, increases mitochondrial ferritin, and protects from ferroptosis
Fuhrmann, D. C., Mondorf, A., Beifuß, J., Jung, M., & Brüne, B. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101670 · Cited by 405
Hu, K., Li, K., Lv, J., Feng, J., Chen, J., Wu, H., Cheng, F., Jiang, W., Wang, J., Pei, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci124049 · Cited by 404
Sato, M., Kusumi, R., Hamashima, S., Kobayashi, S., Sasaki, S., Komiyama, Y., Izumikawa, T., Conrad, M., Bannai, S., & Sato, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-19213-4 · Cited by 403
Organelle-specific regulation of ferroptosis
Chen, X., Kang, R., Kroemer, G., & Tang, D. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-021-00859-z · Cited by 398
Self-citationATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis
He, F., Zhang, P., Liu, J., Wang, R., Kaufman, R. J., Yaden, B. C., & Karin, M. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.016 · Cited by 390
Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells
Ooko, E., Saeed, M. E. M., Kadioglu, O., Sarvi, S., Colak, M., Elmasaoudi, K., Janah, R., Greten, H. J., & Efferth, T. (2015) · Phytomedicine · doi:10.1016/j.phymed.2015.08.002 · Cited by 387
Crespo-Ortiz, M. P., & Wei, M. Q. (2012) · Journal of Biomedicine and Biotechnology · doi:10.1155/2012/247597 · Cited by 382
Contemporary radiotherapy: present and future
Chandra, R. A., Keane, F. K., Voncken, F. E. M., & Thomas, C. R. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00233-6 · Cited by 380
NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer
Chio, I. I. C., Jafarnejad, S. M., Ponz-Sarvise, M., Park, Y., Rivera, K., Palm, W., Wilson, J., Sangar, V., Hao, Y., Öhlund, D., et al. (2016) · Cell · doi:10.1016/j.cell.2016.06.056 · Cited by 378 · cited 1×
“204 207 However, once oncogenic driver mutations occur, the high expression status of NRF2 in cancer cells may promote tumor progression and therapeutic resistance, 208,209 partly through its ability to defend against ferroptosis.”
BackgroundInduction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer
Roh, J.-L., Kim, E. H., Jang, H. J., Park, J. Y., & Shin, D. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.07.035 · Cited by 373
Paradkar, P. N., Zumbrennen, K. B., Paw, B. H., Ward, D. M., & Kaplan, J. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01685-08 · Cited by 363
Necroptosis and ferroptosis are alternative cell death pathways that operate in acute kidney failure
Müller, T., Dewitz, C., Schmitz, J., Schröder, A. S., Bräsen, J. H., Stockwell, B. R., Murphy, J. M., Kunzendorf, U., & Krautwald, S. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2547-4 · Cited by 357
Immunosuppression associated with chronic inflammation in the tumor microenvironment
Wang, D., & DuBois, R. N. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv123 · Cited by 355
Jennis, M., Kung, C.-P., Basu, S., Budina-Kolomets, A., Leu, J. I.-J., Khaku, S., Scott, J. P., Cai, K. Q., Campbell, M. R., Porter, D. K., et al. (2016) · Genes & Development · doi:10.1101/gad.275891.115 · Cited by 352
Phase separation of FSP1 promotes ferroptosis
Nakamura, T., Hipp, C., Santos Dias Mourão, A., Borggräfe, J., Aldrovandi, M., Henkelmann, B., Wanninger, J., Mishima, E., Lytton, E., Emler, D., et al. (2023) · Nature · doi:10.1038/s41586-023-06255-6 · Cited by 352
An essential role for functional lysosomes in ferroptosis of cancer cells
Torii, S., Shintoku, R., Kubota, C., Yaegashi, M., Torii, R., Sasaki, M., Suzuki, T., Mori, M., Yoshimoto, Y., Takeuchi, T., et al. (2016) · Biochemical Journal · doi:10.1042/bj20150658 · Cited by 349
iPLA2β-mediated lipid detoxification controls p53-driven ferroptosis independent of GPX4
Chen, D., Chu, B., Yang, X., Liu, Z., Jin, Y., Kon, N., Rabadan, R., Jiang, X., Stockwell, B. R., & Gu, W. (2021) · Nature Communications · doi:10.1038/s41467-021-23902-6 · Cited by 348
The epigenetic regulators and metabolic changes in ferroptosis-associated cancer progression
Wu, Y., Zhang, S., Gong, X., Tam, S., Xiao, D., Liu, S., & Tao, Y. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01157-x · Cited by 344
Epithelial–mesenchymal transition: a new target in anticancer drug discovery
Marcucci, F., Stassi, G., & De Maria, R. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.13 · Cited by 342
Liu, W., Chakraborty, B., Safi, R., Kazmin, D., Chang, C.-Y., & McDonnell, D. P. (2021) · Nature Communications · doi:10.1038/s41467-021-25354-4 · Cited by 341
Gaschler, M. M., Hu, F., Feng, H., Linkermann, A., Min, W., & Stockwell, B. R. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00199 · Cited by 340
Phospholipase iPLA2β averts ferroptosis by eliminating a redox lipid death signal
Sun, W.-Y., Tyurin, V. A., Mikulska-Ruminska, K., Shrivastava, I. H., Anthonymuthu, T. S., Zhai, Y.-J., Pan, M.-H., Gong, H.-B., Lu, D.-H., Sun, J., et al. (2021) · Nature Chemical Biology · doi:10.1038/s41589-020-00734-x · Cited by 337 · cited 1×
“189 For instance, iPLA2 β , which cleaves and detoxi fi es peroxidized lipids to avert ferroptosis, is overexpressed in some human cancers and is involved in inhibiting p53-mediated ferroptosis and tumor suppression.”
BackgroundTHE SPECIFIC AMINO ACID REQUIREMENTS OF A HUMAN CARCINOMA CELL (STRAIN H E L A) IN TISSUE CULTURE
Eagle, H. (1955) · The Journal of Experimental Medicine · doi:10.1084/jem.102.1.37 · Cited by 336 · cited 2×
“26,27 Dietary cystine and selenium in 1959 were further found to signi fi cantly reduce peroxidation in the liver and muscle of vitamin E-de fi cient chicks.”
BackgroundThe isoprostanes—25 years later
Milne, G. L., Dai, Q., & Roberts, L. J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.10.007 · Cited by 335
Mitochondrial glutathione peroxidase 4 disruption causes male infertility
Schneider, M., Forster, H., Boersma, A., Seiler, A., Wehnes, H., Sinowatz, F., Neumüller, C., Deutsch, M. J., Walch, A., de Angelis, M. H., et al. (2009) · The FASEB Journal · doi:10.1096/fj.09-132795 · Cited by 332
Bianchi, M. E., Crippa, M. P., Manfredi, A. A., Mezzapelle, R., Rovere Querini, P., & Venereau, E. (2017) · Immunological Reviews · doi:10.1111/imr.12601 · Cited by 330
The small GTPase Rab7 as a central regulator of hepatocellular lipophagy
Schroeder, B., Schulze, R. J., Weller, S. G., Sletten, A. C., Casey, C. A., & McNiven, M. A. (2015) · Hepatology · doi:10.1002/hep.27667 · Cited by 329
Epigenetic modulation of antitumor immunity for improved cancer immunotherapy
Dai, E., Zhu, Z., Wahed, S., Qu, Z., Storkus, W. J., & Guo, Z. S. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01464-x · Cited by 328
TYRO3 induces anti–PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis
Jiang, Z., Lim, S.-O., Yan, M., Hsu, J. L., Yao, J., Wei, Y., Chang, S.-S., Yamaguchi, H., Lee, H.-H., Ke, B., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci139434 · Cited by 325
NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression
Chen, D., Tavana, O., Chu, B., Erber, L., Chen, Y., Baer, R., & Gu, W. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.09.009 · Cited by 317
Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma
Li, Z.-J., Dai, H.-Q., Huang, X.-W., Feng, J., Deng, J.-H., Wang, Z.-X., Yang, X.-M., Liu, Y.-J., Wu, Y., Chen, P.-H., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0478-3 · Cited by 315
Self-citationFerroptotic pores induce Ca2+ fluxes and ESCRT-III activation to modulate cell death kinetics
Pedrera, L., Espiritu, R. A., Ros, U., Weber, J., Schmitt, A., Stroh, J., Hailfinger, S., von Karstedt, S., & García-Sáez, A. J. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-020-00691-x · Cited by 314
Hao, X., Zheng, Z., Liu, H., Zhang, Y., Kang, J., Kong, X., Rong, D., Sun, G., Sun, G., Liu, L., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102463 · Cited by 314
Ren, X., Li, Y., Zhou, Y., Hu, W., Yang, C., Jing, Q., Zhou, C., Wang, X., Hu, J., Wang, L., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102122 · Cited by 313
Song, R., Li, T., Ye, J., Sun, F., Hou, B., Saeed, M., Gao, J., Wang, Y., Zhu, Q., Xu, Z., et al. (2021) · Advanced Materials · doi:10.1002/adma.202101155 · Cited by 308
The Protective Role of Mitochondrial Ferritin on Erastin-Induced Ferroptosis
Wang, Y.-Q., Chang, S.-Y., Wu, Q., Gou, Y.-J., Jia, L., Cui, Y.-M., Yu, P., Shi, Z.-H., Wu, W.-S., Gao, G., et al. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00308 · Cited by 307
Qi, R., Bai, Y., Li, K., Liu, N., Xu, Y., Dal, E., Wang, Y., Lin, R., Wang, H., Liu, Z., et al. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.100960 · Cited by 307
Chen, Q., Zheng, W., Guan, J., Liu, H., Dan, Y., Zhu, L., Song, Y., Zhou, Y., Zhao, X., Zhang, Y., et al. (2023) · Cell Death & Differentiation · doi:10.1038/s41418-022-01051-7 · Cited by 304
Padanad, M. S., Konstantinidou, G., Venkateswaran, N., Melegari, M., Rindhe, S., Mitsche, M., Yang, C., Batten, K., Huffman, K. E., Liu, J., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.009 · Cited by 301
Yang, W.-H., Huang, Z., Wu, J., Ding, C.-K. C., Murphy, S. K., & Chi, J.-T. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0691 · Cited by 301
Ferroptosis Detection: From Approaches to Applications
Zeng, F., Nijiati, S., Tang, L., Ye, J., Zhou, Z., & Chen, X. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202300379 · Cited by 300
Self-citationSun, Y., Berleth, N., Wu, W., Schlütermann, D., Deitersen, J., Stuhldreier, F., Berning, L., Friedrich, A., Akgün, S., Mendiburo, M. J., et al. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-04306-2 · Cited by 294
Self-citationPharmacokinetics of Haloperidol
Froemming, J. S., Lam, Y. W. F., Jann, M. W., & Davis, C. M. (1989) · Clinical Pharmacokinetics · doi:10.2165/00003088-198917060-00004 · Cited by 291
Programmed Necrosis, Not Apoptosis, in the Heart
Kung, G., Konstantinidis, K., & Kitsis, R. N. (2011) · Circulation Research · doi:10.1161/circresaha.110.225730 · Cited by 291
CD44 regulates epigenetic plasticity by mediating iron endocytosis
Müller, S., Sindikubwabo, F., Cañeque, T., Lafon, A., Versini, A., Lombard, B., Loew, D., Wu, T.-D., Ginestier, C., Charafe-Jauffret, E., et al. (2020) · Nature Chemistry · doi:10.1038/s41557-020-0513-5 · Cited by 288
B Cell Function in the Tumor Microenvironment
Downs-Canner, S. M., Meier, J., Vincent, B. G., & Serody, J. S. (2022) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101220-015603 · Cited by 287
Fu, D., Wang, C., Yu, L., & Yu, R. (2021) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-021-00271-y · Cited by 283
Saito, A., Ochiai, K., Kondo, S., Tsumagari, K., Murakami, T., Cavener, D. R., & Imaizumi, K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.152900 · Cited by 282
Pfeifer, H., Conrad, M., Roethlein, D., Kyriakopoulos, A., Brielmeier, M., Bornkamm, G. W., & Behne, D. (2001) · The FASEB Journal · doi:10.1096/fj.00-0655fje · Cited by 281
ESCRT-III–dependent membrane repair blocks ferroptosis
Dai, E., Meng, L., Kang, R., Wang, X., & Tang, D. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.11.110 · Cited by 273
Li, H., Yang, P., Wang, J., Zhang, J., Ma, Q., Jiang, Y., Wu, Y., Han, T., & Xiang, D. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01223-x · Cited by 273
Poursaitidis, I., Wang, X., Crighton, T., Labuschagne, C., Mason, D., Cramer, S. L., Triplett, K., Roy, R., Pardo, O. E., Seckl, M. J., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.054 · Cited by 272
Molecular basis for redox control by the human cystine/glutamate antiporter system xc−
Parker, J. L., Deme, J. C., Kolokouris, D., Kuteyi, G., Biggin, P. C., Lea, S. M., & Newstead, S. (2021) · Nature Communications · doi:10.1038/s41467-021-27414-1 · Cited by 272
Conrad, M., Moreno, S. G., Sinowatz, F., Ursini, F., Kölle, S., Roveri, A., Brielmeier, M., Wurst, W., Maiorino, M., & Bornkamm, G. W. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.17.7637-7644.2005 · Cited by 270
Yu, B., Choi, B., Li, W., & Kim, D.-H. (2020) · Nature Communications · doi:10.1038/s41467-020-17380-5 · Cited by 262
TGF-β signaling in the tumor metabolic microenvironment and targeted therapies
Shi, X., Yang, J., Deng, S., Xu, H., Wu, D., Zeng, Q., Wang, S., Hu, T., Wu, F., & Zhou, H. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01349-6 · Cited by 262
Conche, C., Finkelmeier, F., Pešić, M., Nicolas, A. M., Böttger, T. W., Kennel, K. B., Denk, D., Ceteci, F., Mohs, K., Engel, E., et al. (2023) · Gut · doi:10.1136/gutjnl-2022-327909 · Cited by 262
Kim, E. H., Shin, D., Lee, J., Jung, A. R., & Roh, J.-L. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.06.018 · Cited by 261
Luo, X., Gong, H.-B., Gao, H.-Y., Wu, Y.-P., Sun, W.-Y., Li, Z.-Q., Wang, G., Liu, B., Liang, L., Kurihara, H., et al. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-020-00719-2 · Cited by 261
ATM orchestrates ferritinophagy and ferroptosis by phosphorylating NCOA4
Wu, H., Liu, Q., Shan, X., Gao, W., & Chen, Q. (2023) · Autophagy · doi:10.1080/15548627.2023.2170960 · Cited by 255
Wan, C., Sun, Y., Tian, Y., Lu, L., Dai, X., Meng, J., Huang, J., He, Q., Wu, B., Zhang, Z., et al. (2020) · Science Advances · doi:10.1126/sciadv.aay9789 · Cited by 251
Self-citationCharacterization of hypoxia-associated molecular features to aid hypoxia-targeted therapy
Ye, Y., Hu, Q., Chen, H., Liang, K., Yuan, Y., Xiang, Y., Ruan, H., Zhang, Z., Song, A., Zhang, H., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0045-8 · Cited by 250
Tumor heterogeneity in autophagy-dependent ferroptosis
Li, J., Liu, J., Xu, Y., Wu, R., Chen, X., Song, X., Zeh, H., Kang, R., Klionsky, D. J., Wang, X., et al. (2021) · Autophagy · doi:10.1080/15548627.2021.1872241 · Cited by 245
Self-citationYang, Z., Su, W., Wei, X., Qu, S., Zhao, D., Zhou, J., Wang, Y., Guan, Q., Qin, C., Xiang, J., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112945 · Cited by 245
Ferroptosis is a lysosomal cell death process
Gao, H., Bai, Y., Jia, Y., Zhao, Y., Kang, R., Tang, D., & Dai, E. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.07.078 · Cited by 244
Identification of Frataxin as a regulator of ferroptosis
Du, J., Zhou, Y., Li, Y., Xia, J., Chen, Y., Chen, S., Wang, X., Sun, W., Wang, T., Ren, X., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101483 · Cited by 243
Yang, M., Wu, X., Hu, J., Wang, Y., Wang, Y., Zhang, L., Huang, W., Wang, X., Li, N., Liao, L., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.01.009 · Cited by 243
Bartha, I., di Iulio, J., Venter, J. C., & Telenti, A. (2018) · Nature Reviews Genetics · doi:10.1038/nrg.2017.75 · Cited by 237
Peroxisome-driven ether-linked phospholipids biosynthesis is essential for ferroptosis
Cui, W., Liu, D., Gu, W., & Chu, B. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-021-00769-0 · Cited by 237
Hong, X., Roh, W., Sullivan, R. J., Wong, K. H. K., Wittner, B. S., Guo, H., Dubash, T. D., Sade-Feldman, M., Wesley, B., Horwitz, E., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1500 · Cited by 234
Impaired lysosomal acidification triggers iron deficiency and inflammation in vivo
Yambire, K. F., Rostosky, C., Watanabe, T., Pacheu-Grau, D., Torres-Odio, S., Sanchez-Guerrero, A., Senderovich, O., Meyron-Holtz, E. G., Milosevic, I., Frahm, J., et al. (2019) · eLife · doi:10.7554/elife.51031 · Cited by 232
AIFM2 blocks ferroptosis independent of ubiquinol metabolism
Dai, E., Zhang, W., Cong, D., Kang, R., Wang, J., & Tang, D. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.01.066 · Cited by 232
Diverse compounds from pleuromutilin lead to a thioredoxin inhibitor and inducer of ferroptosis
Llabani, E., Hicklin, R. W., Lee, H. Y., Motika, S. E., Crawford, L. A., Weerapana, E., & Hergenrother, P. J. (2019) · Nature Chemistry · doi:10.1038/s41557-019-0261-6 · Cited by 230
Simvastatin induced ferroptosis for triple-negative breast cancer therapy
Yao, X., Xie, R., Cao, Y., Tang, J., Men, Y., Peng, H., & Yang, W. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01058-1 · Cited by 227
Lee, J., You, J. H., Kim, M.-S., & Roh, J.-L. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101697 · Cited by 222
LKB1-AMPK axis negatively regulates ferroptosis by inhibiting fatty acid synthesis
Li, C., Dong, X., Du, W., Shi, X., Chen, K., Zhang, W., & Gao, M. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00297-2 · Cited by 221
Tang, B., Zhu, J., Wang, Y., Chen, W., Fang, S., Mao, W., Xu, Z., Yang, Y., Weng, Q., Zhao, Z., et al. (2023) · Advanced Science · doi:10.1002/advs.202203973 · Cited by 221
Molecular Pathways: Targeted α-Particle Radiation Therapy
Baidoo, K. E., Yong, K., & Brechbiel, M. W. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0298 · Cited by 217
HIF-2α activation potentiates oxidative cell death in colorectal cancers by increasing cellular iron
Singhal, R., Mitta, S. R., Das, N. K., Kerk, S. A., Sajjakulnukit, P., Solanki, S., Andren, A., Kumar, R., Olive, K. P., Banerjee, R., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143691 · Cited by 215 · cited 1×
“235 Similarly, the activation of HIF2 α increases hypoxia-inducible lipid droplet-associated protein (HILPDA) expression, driving the accumulation of PUFAs and subsequent lipid peroxidation, which contributes to the vulnerability of clear-cell carcinomas to ferroptosis.”
BackgroundEpigenetic regulation of ferroptosis by H2B monoubiquitination and p53
Wang, Y., Yang, L., Zhang, X., Cui, W., Liu, Y., Sun, Q., He, Q., Zhao, S., Zhang, G., Wang, Y., et al. (2019) · EMBO reports · doi:10.15252/embr.201847563 · Cited by 214
Self-citationCrystal Structures of Nucleotide-Free and Glutathione-Bound Mitochondrial ABC Transporter Atm1
Srinivasan, V., Pierik, A. J., & Lill, R. (2014) · Science · doi:10.1126/science.1246729 · Cited by 212
Yan, Y., Huang, L., Liu, Y., Yi, M., Chu, Q., Jiao, D., & Wu, K. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01322-3 · Cited by 212
Self-citationHu, Q., Zhang, Y., Lou, H., Ou, Z., Liu, J., Duan, W., Wang, H., Ge, Y., Min, J., Wang, F., et al. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-04008-9 · Cited by 210
Hong, S. H., Lee, D.-H., Lee, Y.-S., Jo, M. J., Jeong, Y. A., Kwon, W. T., Choudry, H. A., Bartlett, D. L., & Lee, Y. J. (2017) · Oncotarget · doi:10.18632/oncotarget.23046 · Cited by 209
Exosomal miRNAs in tumor microenvironment
Tan, S., Xia, L., Yi, P., Han, Y., Tang, L., Pan, Q., Tian, Y., Rao, S., Oyang, L., Liang, J., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01570-6 · Cited by 207
Curcumenol triggered ferroptosis in lung cancer cells via lncRNA H19/miR-19b-3p/FTH1 axis
Zhang, R., Pan, T., Xiang, Y., Zhang, M., Xie, H., Liang, Z., Chen, B., Xu, C., Wang, J., Huang, X., et al. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.11.013 · Cited by 205
Ferroptosis: A flexible constellation of related biochemical mechanisms
Dixon, S. J., & Pratt, D. A. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.03.005 · Cited by 205
Emerging New Concepts of Degrader Technologies
Ding, Y., Fei, Y., & Lu, B. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.04.005 · Cited by 204 · cited 1×
“Developing small molecules compatible with in vivo conditions and exploring targeted protein degradation technologies, such as proteolysis-targeting chimaeras (PROTACs) 499,500 and lysosome-targeting chi-maera, 499,501 offer promising strategies.”
BackgroundMa, S., Dielschneider, R. F., Henson, E. S., Xiao, W., Choquette, T. R., Blankstein, A. R., Chen, Y., & Gibson, S. B. (2017) · PLOS ONE · doi:10.1371/journal.pone.0182921 · Cited by 203
A Physiological Function for Ferroptosis in Tumor Suppression by the Immune System
Stockwell, B. R., & Jiang, X. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.06.012 · Cited by 203
DHODH inhibitors sensitize to ferroptosis by FSP1 inhibition
Mishima, E., Nakamura, T., Zheng, J., Zhang, W., Mourão, A. S. D., Sennhenn, P., & Conrad, M. (2023) · Nature · doi:10.1038/s41586-023-06269-0 · Cited by 199
Muri, J., Thut, H., Bornkamm, G. W., & Kopf, M. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.070 · Cited by 198 · cited 1×
“345 Moreover, ferroptosis has been observed in B cells from both systemic lupus erythematosus patients and mice, suggesting that it may regulate B cell differentiation and plasma cell formation to participate in the pathogenesis of lupus.”
BackgroundDu, J., Wang, X., Li, Y., Ren, X., Zhou, Y., Hu, W., Zhou, C., Jing, Q., Yang, C., Wang, L., et al. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-03996-y · Cited by 197
Chemotherapy impairs ovarian function through excessive ROS-induced ferroptosis
Zhang, S., Liu, Q., Chang, M., Pan, Y., Yahaya, B. H., Liu, Y., & Lin, J. (2023) · Cell Death & Disease · doi:10.1038/s41419-023-05859-0 · Cited by 196
Self-citationRat Phospholipid-hydroperoxide Glutathione Peroxidase
Pushpa-Rekha, T. R., Burdsall, A. L., Oleksa, L. M., Chisolm, G. M., & Driscoll, D. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26993 · Cited by 195
Tamir, S., Paddock, M. L., Darash-Yahana-Baram, M., Holt, S. H., Sohn, Y. S., Agranat, L., Michaeli, D., Stofleth, J. T., Lipper, C. H., Morcos, F., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.10.014 · Cited by 192
Pharmacologic Screening Identifies Metabolic Vulnerabilities of CD8+ T Cells
Drijvers, J. M., Gillis, J. E., Muijlwijk, T., Nguyen, T. H., Gaudiano, E. F., Harris, I. S., LaFleur, M. W., Ringel, A. E., Yao, C.-H., Kurmi, K., et al. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0384 · Cited by 191
Liang, H., Yoo, S.-E., Na, R., Walter, C. A., Richardson, A., & Ran, Q. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.032839 · Cited by 190
Sorafenib fails to trigger ferroptosis across a wide range of cancer cell lines
Zheng, J., Sato, M., Mishima, E., Sato, H., Proneth, B., & Conrad, M. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-03998-w · Cited by 190
ACSL4, PUFA, and ferroptosis: new arsenal in anti-tumor immunity
Gan, B. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01004-z · Cited by 189
Su, N., & Kilberg, M. S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806874200 · Cited by 186
Autophagy and Ferroptosis—What Is the Connection?
Kang, R., & Tang, D. (2017) · Current Pathobiology Reports · doi:10.1007/s40139-017-0139-5 · Cited by 185
Ferroptosis, a Recent Defined Form of Critical Cell Death in Neurological Disorders
Wu, J.-R., Tuo, Q.-Z., & Lei, P. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1155-6 · Cited by 184
Tryptophan Metabolism Acts as a New Anti‐Ferroptotic Pathway to Mediate Tumor Growth
Liu, D., Liang, C., Huang, B., Zhuang, X., Cui, W., Yang, L., Yang, Y., Zhang, Y., Fu, X., Zhang, X., et al. (2023) · Advanced Science · doi:10.1002/advs.202204006 · Cited by 183
Mishima, E., Sato, E., Ito, J., Yamada, K.-I., Suzuki, C., Oikawa, Y., Matsuhashi, T., Kikuchi, K., Toyohara, T., Suzuki, T., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019060570 · Cited by 182
Yan, R., Xie, E., Li, Y., Li, J., Zhang, Y., Chi, X., Hu, X., Xu, L., Hou, T., Stockwell, B. R., et al. (2022) · Cell Research · doi:10.1038/s41422-022-00642-w · Cited by 182
Self-citationJoseph, J. V., Conroy, S., Tomar, T., Eggens-Meijer, E., Bhat, K., Copray, S., Walenkamp, A. M. E., Boddeke, E., Balasubramanyian, V, Wagemakers, M., et al. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.395 · Cited by 178
Creatine kinase B suppresses ferroptosis by phosphorylating GPX4 through a moonlighting function
Wu, K., Yan, M., Liu, T., Wang, Z., Duan, Y., Xia, Y., Ji, G., Shen, Y., Wang, L., Li, L., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01133-9 · Cited by 178
Self-citationZhang, X., Yu, K., Ma, L., Qian, Z., Tian, X., Miao, Y., Niu, Y., Xu, X., Guo, S., Yang, Y., et al. (2021) · Theranostics · doi:10.7150/thno.55482 · Cited by 177
Panda, S. K., Peng, V., Sudan, R., Ulezko Antonova, A., Di Luccia, B., Ohara, T. E., Fachi, J. L., Grajales-Reyes, G. E., Jaeger, N., Trsan, T., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.01.023 · Cited by 174
Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer
Bartolacci, C., Andreani, C., Vale, G., Berto, S., Melegari, M., Crouch, A. C., Baluya, D. L., Kemble, G., Hodges, K., Starrett, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31963-4 · Cited by 173
Growth factors and vitamin E modify neuronal glutamate toxicity
Schubert, D., Kimura, H., & Maher, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.17.8264 · Cited by 172
Albrecht, P., Lewerenz, J., Dittmer, S., Noack, R., Maher, P., & Methner, A. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710791292567 · Cited by 172
Wang, X., Ma, H., Sun, J., Zheng, T., Zhao, P., Li, H., & Yang, M. (2021) · Biological Trace Element Research · doi:10.1007/s12011-021-02627-z · Cited by 172
Kynurenine importation by SLC7A11 propagates anti-ferroptotic signaling
Fiore, A., Zeitler, L., Russier, M., Groß, A., Hiller, M.-K., Parker, J. L., Stier, L., Köcher, T., Newstead, S., & Murray, P. J. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.02.007 · Cited by 172
NK cells are never alone: crosstalk and communication in tumour microenvironments
Zhou, Y., Cheng, L., Liu, L., & Li, X. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01737-7 · Cited by 172
Zhang, D., Man, D., Lu, J., Jiang, Y., Ding, B., Su, R., Tong, R., Chen, J., Yang, B., Zheng, S., et al. (2023) · Advanced Science · doi:10.1002/advs.202206669 · Cited by 171
Zhai, B., Zeng, Y., Zeng, Z., Zhang, N., Li, C., Zeng, Y., You, Y., Wang, S., Chen, X., Sui, X., et al. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s174527 · Cited by 169
Self-citationFerroptosis: mechanisms and implications for cancer development and therapy response
dos Santos, A. F., Fazeli, G., da Silva, T. N. X., & Angeli, J. P. F. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.04.005 · Cited by 169
A promising new approach to cancer therapy: Targeting iron metabolism in cancer stem cells
El Hout, M., Dos Santos, L., Hamaï, A., & Mehrpour, M. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.07.009 · Cited by 168
Wang, Y.-Q., Wang, H.-L., Xu, J., Tan, J., Fu, L.-N., Wang, J.-L., Zou, T.-H., Sun, D.-F., Gao, Q.-Y., Chen, Y.-X., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-02951-4 · Cited by 167
Li, Y., Yang, W., Zheng, Y., Dai, W., Ji, J., Wu, L., Cheng, Z., Zhang, J., Li, J., Xu, X., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02567-z · Cited by 167
Papsdorf, K., Miklas, J. W., Hosseini, A., Cabruja, M., Morrow, C. S., Savini, M., Yu, Y., Silva-García, C. G., Haseley, N. R., Murphy, L., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01136-6 · Cited by 166
Nagpal, A., Redvers, R. P., Ling, X., Ayton, S., Fuentes, M., Tavancheh, E., Diala, I., Lalani, A. S., Loi, S., David, S., et al. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1177-1 · Cited by 164
Ichikawa, Y., Bayeva, M., Ghanefar, M., Potini, V., Sun, L., Mutharasan, R. K., Wu, R., Khechaduri, A., Jairaj Naik, T., & Ardehali, H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119338109 · Cited by 163
Kong, R., Wang, N., Han, W., Bao, W., & Lu, J. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ma1220-815rrr · Cited by 161
Mitochondria regulate intracellular coenzyme Q transport and ferroptotic resistance via STARD7
Deshwal, S., Onishi, M., Tatsuta, T., Bartsch, T., Cors, E., Ried, K., Lemke, K., Nolte, H., Giavalisco, P., & Langer, T. (2023) · Nature Cell Biology · doi:10.1038/s41556-022-01071-y · Cited by 160
Mao, W., Cai, Y., Chen, D., Jiang, G., Xu, Y., Chen, R., Wang, F., Wang, X., Zheng, M., Zhao, X., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.161940 · Cited by 159
TRIM7 modulates NCOA4-mediated ferritinophagy and ferroptosis in glioblastoma cells
Li, K., Chen, B., Xu, A., Shen, J.-L., Li, K., Hao, K., Hao, R., Yang, W. J., Jiang, W., Zheng, Y., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102451 · Cited by 159
A MOF-Based Potent Ferroptosis Inducer for Enhanced Radiotherapy of Triple Negative Breast Cancer
Zeng, L., Ding, S., Cao, Y., Li, C., Zhao, B., Ma, Z., Zhou, J., Hu, Y., Zhang, X., Yang, Y., et al. (2023) · ACS Nano · doi:10.1021/acsnano.3c00048 · Cited by 159
Cui, S., Ghai, A., Deng, Y., Li, S., Zhang, R., Egbulefu, C., Liang, G., Achilefu, S., & Ye, J. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.09.025 · Cited by 159
Elevated FSP1 protects KRAS-mutated cells from ferroptosis during tumor initiation
Müller, F., Lim, J. K. M., Bebber, C. M., Seidel, E., Tishina, S., Dahlhaus, A., Stroh, J., Beck, J., Yapici, F. I., Nakayama, K., et al. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-01096-8 · Cited by 158
Cavadini, P., Biasiotto, G., Poli, M., Levi, S., Verardi, R., Zanella, I., Derosas, M., Ingrassia, R., Corrado, M., & Arosio, P. (2006) · Blood · doi:10.1182/blood-2006-08-041632 · Cited by 157
Liang, J., Jin, X., Zhang, S., Huang, Q.-X., Ji, P., Deng, X.-C., Chen, W., Chen, W., & Zhang, X. (2023) · 中国科学通报:英文版 · doi:10.1016/j.scib.2023.02.027 · Cited by 156
Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells
Rademaker, G., Boumahd, Y., Peiffer, R., Anania, S., Wissocq, T., Liegeois, M. A., Luis, G., Sounni, N. E., Agirman, F., Maloujahmoum, N., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102324 · Cited by 155
Human hematopoietic stem cell vulnerability to ferroptosis
Zhao, J., Jia, Y., Mahmut, D., Deik, A., Jeanfavre, S., Clish, C. B., & Sankaran, V. G. (2023) · Cell · doi:10.1016/j.cell.2023.01.020 · Cited by 153
Biological Actions of Artemisinin: Insights from Medicinal Chemistry Studies
Li, J., & Zhou, B. (2010) · Molecules · doi:10.3390/molecules15031378 · Cited by 152
Haloperidol, a sigma receptor 1 antagonist, promotes ferroptosis in hepatocellular carcinoma cells
Bai, T., Wang, S., Zhao, Y., Zhu, R., Wang, W., & Sun, Y. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.07.136 · Cited by 151
Self-citationA role for divalent metal transporter (DMT1) in mitochondrial uptake of iron and manganese
Wolff, N. A., Garrick, M. D., Zhao, L., Garrick, L. M., Ghio, A. J., & Thévenod, F. (2018) · Scientific Reports · doi:10.1038/s41598-017-18584-4 · Cited by 151
Redox-dependent gating of VDAC by mitoNEET
Lipper, C. H., Stofleth, J. T., Bai, F., Sohn, Y., Roy, S., Mittler, R., Nechushtai, R., Onuchic, J. N., & Jennings, P. A. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1908271116 · Cited by 151
Yao, L., Hou, J., Wu, X., Lu, Y., Jin, Z., Yu, Z., Yu, B., Li, J., Yang, Z., Li, C., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102923 · Cited by 149
Self-citationRAS mutations in human cancers: Roles in precision medicine
Murugan, A. K., Grieco, M., & Tsuchida, N. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.06.007 · Cited by 146
Liby, K. T., Royce, D. B., Williams, C. R., Risingsong, R., Yore, M. M., Honda, T., Gribble, G. W., Dmitrovsky, E., Sporn, T. A., & Sporn, M. B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4534 · Cited by 146
Tao, S., de la Vega, M. R., Chapman, E., Ooi, A., & Zhang, D. D. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22745 · Cited by 146
The autoxidation of arachidonic acid: Formation of the proposed SRS-A intermediate
Porter, N. A., Wolf, R. A., Yarbro, E. M., & Weenen, H. (1979) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(79)92115-6 · Cited by 145
De novo pyrimidine biosynthetic complexes support cancer cell proliferation and ferroptosis defence
Yang, C., Zhao, Y., Wang, L., Guo, Z., Ma, L., Yang, R., Wu, Y., Li, X., Niu, J., Chu, Q., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01146-4 · Cited by 145
Xue, Y., Lu, F., Chang, Z., Li, J., Gao, Y., Zhou, J., Luo, Y., Lai, Y., Cao, S., Li, X., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40518-0 · Cited by 145
Reduction in mitochondrial iron alleviates cardiac damage during injury
Chang, H., Wu, R., Shang, M., Sato, T., Chen, C., Shapiro, J. S., Liu, T., Thakur, A., Sawicki, K. T., Prasad, S. V. N., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201505748 · Cited by 144
Effect of antioxidants on cultured human diploid fibroblasts exposed to cystine-free medium
Bannai, S., Tsukeda, H., & Okumura, H. (1977) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(77)90623-4 · Cited by 143
Chen, X., Lin, J., Kanekura, T., Su, J., Lin, W., Xie, H., Wu, Y., Li, J., Chen, M., & Chang, J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1536 · Cited by 143
Self-citationIntracellular Delivery of Glutathione Peroxidase Degrader Induces Ferroptosis In Vivo
Luo, T., Zheng, Q., Shao, L., Ma, T., Mao, L., & Wang, M. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202206277 · Cited by 142
Regulation of VKORC1L1 is critical for p53-mediated tumor suppression through vitamin K metabolism
Yang, X. P., Wang, Z., Zandkarimi, F., Liu, Y., Duan, S., Li, Z., Kon, N., Zhang, Z., Jiang, X., Stockwell, B. R., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.06.014 · Cited by 142
Self-citationMammary adipocytes protect triple-negative breast cancer cells from ferroptosis
Xie, Y., Wang, B., Zhao, Y., Tao, Z., Wang, Y., Chen, G., & Hu, X. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01297-1 · Cited by 140
Kang, Y., Tiziani, S., Park, G., Kaul, M., & Paternostro, G. (2014) · Nature Communications · doi:10.1038/ncomms4672 · Cited by 138
PPARG-mediated ferroptosis in dendritic cells limits antitumor immunity
Han, L., Bai, L., Qu, C., Dai, E., Liu, J., Kang, R., Zhou, D., Tang, D., & Zhao, Y. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.08.082 · Cited by 136
Gu, Z., Liu, T., Liu, C., Yang, Y., Tang, J., Song, H., Wang, Y., Yang, Y., & Yu, C. (2021) · Nano Letters · doi:10.1021/acs.nanolett.1c01401 · Cited by 133
A ferroptosis defense mechanism mediated by glycerol-3-phosphate dehydrogenase 2 in mitochondria
Wu, S., Mao, C., Kondiparthi, L., Poyurovsky, M. V., Olszewski, K. L., & Gan, B. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2121987119 · Cited by 132
ACTL6A protects gastric cancer cells against ferroptosis through induction of glutathione synthesis
Yang, Z., Zou, S., Zhang, Y., Zhang, J., Zhang, P., Xiao, L., Xie, Y., Meng, M., Feng, J., Kang, L., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39901-8 · Cited by 132
Markowitsch, S. D., Schupp, P., Lauckner, J., Vakhrusheva, O., Slade, K. S., Mager, R., Efferth, T., Haferkamp, A., & Juengel, E. (2020) · Cancers · doi:10.3390/cancers12113150 · Cited by 131
Targeted nanomedicine in cisplatin-based cancer therapeutics
Han, Y., Wen, P., Li, J., & Kataoka, K. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.03.049 · Cited by 131
Sun, L., Dong, H., Zhang, W., Wang, N., Ni, N., Bai, X., & Liu, N. (2020) · DNA and Cell Biology · doi:10.1089/dna.2020.5730 · Cited by 130
Atorvastatin Induces Mitochondria-Dependent Ferroptosis via the Modulation of Nrf2-xCT/GPx4 Axis
Zhang, Q., Qu, H., Chen, Y., Luo, X., Chen, C., Xiao, B., Ding, X., Zhao, P., Lu, Y., Chen, A. F., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.806081 · Cited by 130
Maiorino, M., Scapin, M., Ursini, F., Biasolo, M. A., Bosello-Travain, V., & Flohé, L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305327200 · Cited by 128
Wang, D., Li, X., Jiao, D., Cai, Y., Qian, L., Shen, Y., Lu, Y., Zhou, Y., Fu, B., Sun, R., et al. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01429-1 · Cited by 127
Han, Y., Zhang, Y., Pan, Y., Zheng, X., Liao, K. L., Mo, H., Sheng, H., Wu, Q., Liu, Z., Zeng, Z.-L., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.05.011 · Cited by 127
Chang, K. S., Chen, Y., Zhang, X., Zhang, W., Xu, N., Zeng, B., Wang, Y., Feng, T., Dai, B., Xu, F., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-4001 · Cited by 127
12/15-lipoxygenase–mediated enzymatic lipid oxidation regulates DC maturation and function
Rothe, T., Грубер, Ф., Uderhardt, S., Ipseiz, N., Rößner, S., Oskolkova, O., Blüml, S., Leitinger, N., Bicker, W., Bochkov, V. N., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78490 · Cited by 123
Koeberle, S. C., Kipp, A. P., Stuppner, H., & Koeberle, A. (2023) · Medicinal Research Reviews · doi:10.1002/med.21933 · Cited by 122
Induction of cystine transport activity in human fibroblasts by oxygen
Bannai, S., Sato, H., Ishii, T., & Sugita, Y. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)51491-5 · Cited by 121
Regulation of Cell Survival and Death by Pyridine Nucleotides
Oka, S., Hsu, C., & Sadoshima, J. (2012) · Circulation Research · doi:10.1161/circresaha.111.247932 · Cited by 121
Wang, X., Li, Y., Li, Z., Lin, S., Wang, H., Sun, J., Lan, C., Wu, L., Sun, D., Huang, C., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-3230 · Cited by 118
MEX3A Mediates p53 Degradation to Suppress Ferroptosis and Facilitate Ovarian Cancer Tumorigenesis
Wang, C., Chen, T.-J., Tan, G. Y. T., Chang, F., Sridharan, S., Yu, C.-H. A., Chang, Y., Chen, Y., Cheng, L.-T., & Hwang‐Verslues, W. W. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-1159 · Cited by 118
L-kynurenine induces NK cell loss in gastric cancer microenvironment via promoting ferroptosis
Cui, J., Xu, X.-H., He, T., Liu, J.-J., Xie, T.-Y., Tian, W., & Liu, J.-Y. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02629-w · Cited by 118
Liu, S., Zhang, H., Li, J., Ye, Z., Du, T., Li, L., Guo, Y.-Q., Yang, D., Li, Z., Cao, J.-H., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102677 · Cited by 117
Li, Q., Chen, K., Zhang, T., Jiang, D., Chen, L., Jiang, J., Zhang, C., & Li, S. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175913 · Cited by 117
Yuan, B., Liao, F., Shi, Z., Ren, Y., Deng, X., Yang, T.-T., Li, D.-Y., Li, R.-F., Pu, D., Wang, Y., et al. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s248492 · Cited by 115
Self-citationXiao, L., Ma, X., Ye, L., Su, P., Xiong, W., Bi, E., Wang, Q., Xian, M., Yang, M., Qian, J., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci153247 · Cited by 115
Sun, T., & Chi, J. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.05.004 · Cited by 113
PGRMC1-dependent lipophagy promotes ferroptosis in paclitaxel-tolerant persister cancer cells
You, J. H., Lee, J., & Roh, J. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02168-2 · Cited by 113
Fang, C., Mo, F., Liu, L., Du, J., Luo, M., Men, K., Na, F., Wang, W., Yang, H., & Wei, X. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0456-1 · Cited by 111
Leu, J. I.-J., Murphy, M. E., & George, D. L. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1821277116 · Cited by 110
Xu, X., Li, Y., Wu, Y., Wang, M., Lu, Y., Fang, Z., Wang, H., & Li, Y. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102564 · Cited by 109
Shen, D., Luo, J., Chen, L., Ma, W., Mao, X., Zhang, Y., Zheng, J., Wang, Y., Wan, J., Wang, S., et al. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215919 · Cited by 108
Meng, J., Yang, X. F., Huang, J., Tuo, Z., Hu, Y., Liao, Z., Tian, Y., Deng, S., Deng, Y., Zhou, Z., et al. (2023) · Advanced Science · doi:10.1002/advs.202300517 · Cited by 108
Self-citationZhang, Q., Xiong, L., Wei, T., Liu, Q., Yan, L., Chen, J., Dai, L., Shi, L., Zhang, W., Yang, J., et al. (2023) · Oncogene · doi:10.1038/s41388-023-02665-y · Cited by 105
Ding, Q., Tang, W., Li, X., Ding, Y., Chen, X., Cao, W., Wang, X., Mo, W., Su, Z., Zhang, Q. H., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.09.024 · Cited by 105
Self-citationTan, S. K., Mahmud, I., Fontanesi, F., Puchowicz, M., Neumann, C. K. A., Griswold, A. J., Patel, R., Dispagna, M., Ahmed, H. H., Gonzalgo, M. L., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1453 · Cited by 104
Kong, P., Yang, M., Wang, Y., Yu, K. N., Wu, L., & Han, W. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102857 · Cited by 103
Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemia
Pardieu, B., Pasanisi, J., Ling, F., Bello, R. D., Penneroux, J., Su, A. H., Joudinaud, R., Chat, L., Wu, H.-C., Duchmann, M., et al. (2022) · Leukemia · doi:10.1038/s41375-022-01573-6 · Cited by 102
Wang, Z., Li, R., Hou, N., Zhang, J., Wang, T., Fan, P., Ji, C., Zhang, B., Liu, L., Wang, Y., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-006890 · Cited by 101
Feldmann, G. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80491-6 · Cited by 100
Zhang, X., Guo, Y., Li, H., & Han, L. (2021) · Journal of Cancer · doi:10.7150/jca.58500 · Cited by 99
LATS suppresses mTORC1 activity to directly coordinate Hippo and mTORC1 pathways in growth control
Gan, W., Dai, X., Dai, X., Xie, J., Yin, S., Zhu, J., Wang, C., Liu, Y., Guo, J., Wang, M., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0463-6 · Cited by 98
Self-citation
Metadata
- Authors
- Zhou, Q., Meng, Y., Li, D., Yao, L., Le, J., Liu, Y., Sun, Y., Zeng, F., Chen, X., & Deng, G.
- Venue
- Signal Transduction and Targeted Therapy
- Published
- 2024-03-08
- Volume
- 9
- Issue
- 1
- Pages
- 55-55
- ISSN
- 2059-3635 (ISSN-L)
- OpenAlex
- W4392757206
- Cited by
- 890
- References
- 491
- FWCI
- 227.08
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.